Mark Briggs

Mark Briggs has extensive experience in quality assurance and compliance within the clinical and pharmacovigilance sectors. Currently serving as a Quality Assurance and Compliance Associate Clinical and Pharmacovigilance Auditor at Dermal Laboratories Limited since February 2018, Mark focuses on quality improvements and procedure development. Prior to this role, Mark held positions such as Senior Quality Assurance Auditor at GW Pharmaceuticals plc, where responsibilities included auditor training and site preparation for FDA and MHRA inspections. Mark's tenure at MedImmune included roles as CQA Associate Director and GCP Quality Compliance Manager, concentrating on organizing audits for vendors and investigator sites. Mark's career at GlaxoSmithKline spanned nearly 18 years as Clinical Manager, overseeing a team of Regional Clinical Study Managers and coordinating global clinical projects. Education was completed at Rhyl High School and Ysgol Llewelyn.